SNF admissions software
How AdmitScore organizes payer, clinical, documentation, medication, and facility fit signals before bed hold.
AdmitScore™ is paused while we make some improvements.
We are not taking new pilots or processing referral packets right now, and we are sorry for
the interruption. If you already work with us, reach us at
info@verisightanalytics.com
with any account or records questions. Please do not send patient records or PHI through
this website or by email.
Medicare Advantage Review
Authorization readiness before the SNF says yes.
AdmitScore™ helps admissions teams flag Medicare Advantage payer signals, prior authorization questions, skilled-need documentation gaps, and verification steps before making an admission decision.
2026 denial and appeal landscape
The 2026 Medicare Advantage denial picture for SNF admissions.
Medicare Advantage now covers more than half of Medicare. KFF counts 55% of eligible beneficiaries, 35.2 million of 64.2 million people with both Part A and Part B, enrolled in MA plans in 2026. For most admissions teams that makes prior authorization the default condition of referral review, not the exception. Source: KFF, Medicare Advantage in 2026.
The numbers below come from primary sources: HHS OIG, KFF, and MedPAC. Treat them as planning context for how you staff and sequence payer review. They do not predict how any plan will decide any referral.
12% of SNF prior-auth requests denied
In a June 2026 report, HHS OIG reviewed 19 Medicare Advantage organizations and found they denied 12% of SNF admission prior-authorization requests in June 2024. Denial rates ranged from 0.4% to 23% by insurer, and requests for enrollees already living in nursing homes were denied at 40%, versus 11% for other enrollees. The plan on the face sheet matters. Source: HHS OIG, OEI-09-24-00331.
95% overturned on appeal, but only 18% appealed
The same OIG review found that when SNF denials were appealed, plans overturned 95% in favor of the enrollee. Only 18% of denials were appealed at all. Read both numbers together: appeals are neither futile nor automatic wins, and the overturn rate describes the small appealed share, not the odds on any single case. OIG's own framing is that the overturn rate raises concerns about the initial denials. Source: HHS OIG, OEI-09-24-00331.
About $20,970 per Medicare-covered SNF stay
MedPAC's March 2026 report puts average fee-for-service Medicare payment at $20,970 per SNF stay, including beneficiary cost sharing, across a mean 30.7 covered days. MA plans pay negotiated rates that vary by contract, but the scale is why days lost to authorization clarification cycles are worth sizing in your own numbers. Source: MedPAC, March 2026, Table 6-2.
What to verify before accepting
Many of the items that later show up in denial notices are checkable before the bed hold: payer and member ID against the portal, network status for the specific MA product, authorization scope in writing, carve-outs, and skilled-need documentation. The eight-point checklist below walks the full list, and the no-PHI documentation checklist structures the packet review.
What to do when a denial arrives
Medicare rules set the initial reconsideration filing window, and the denial notice gives the applicable deadline and appeal instructions. Teams typically verify the written denial reason and instructions against current CMS Part C reconsideration guidance and the plan's Evidence of Coverage, then assemble the documentation the notice cites as missing. KFF's program-wide data shows the same shape as OIG's SNF findings: of 52.8 million MA prior-auth determinations in 2024, 7.7% were denied, 11.5% of denials were appealed, and 80.7% of appeals were fully or partially overturned. Source: KFF, January 2026.
Where AdmitScore fits: planning context
AdmitScore reads the referral packet and surfaces authorization-readiness signals for staff review: payer questions, authorization scope, skilled-need documentation gaps, and follow-up questions for the case manager or payer. Signals are planning context to verify against source documents, not payer determinations, and facility staff make the final decision on every referral. The synthetic sample report shows the format.
Statistics reflect the most recent public data as of July 2026: HHS OIG (June 2026), KFF (January and June 2026), and MedPAC (March 2026). MA prior-auth volumes are program-wide across care settings; the 12%, 18%, and 95% figures are specific to SNF admission requests.
What AdmitScore flags
Authorization risk is rarely just one missing field.
The platform is intended to assist review. It does not guarantee payer approval, reimbursement, admission outcomes, or denial prevention.
Payer detected by AI
Shows payer information that should be verified against the referral packet, eligibility checks, and payer portal.
Authorization readiness
Flags whether packet content appears to support prior authorization review, pending staff verification.
Skilled need support
Helps identify therapy, nursing, wound, medication, or care documentation that may support SNF level of care.
Missing documentation
Surfaces gaps such as missing therapy evaluations, orders, medication records, or discharge details.
Follow-up questions
Produces questions for the case manager, payer, internal clinical team, or finance reviewer.
Outcome tracking
Tracks recurring authorization and documentation issues by payer, referral source, and facility.
What an MA-ready packet contains
The eight things admissions teams check on every Medicare Advantage referral.
AdmitScore runs through this list automatically and surfaces what's missing. Staff still verify each item against source documents. None of these guarantee payer approval. They're the prerequisites that make approval possible.
- Payer identified and verified. MA plan name, plan type, and member ID match the payer face sheet. Eligibility confirmed against the payer portal before bed hold.
- Benefit period confirmed. Member effective dates active for the planned admission date. Coverage status not terminated, suspended, or pending.
- Network status checked for SNF level of care. Facility in-network for the specific MA product. Out-of-network arrangements negotiated in writing before acceptance, not after.
- Carve-outs reviewed. High-cost meds, dialysis, behavioral health, and DME flagged against carve-out language. Cost exposure understood before bed hold.
- Authorization scope documented. Initial authorized days, escalation pathway, and continued-stay review cadence clear. No assumptions about "we'll get more days later."
- Skilled-need supporting documentation present. Therapy evaluation, nursing notes, medication record, and discharge summary support the SNF level of care being requested.
- Expected stay context reviewed. If the packet implies a longer or shorter stay than the team expects, staff can verify assumptions with payer and clinical reviewers before acceptance.
- Denial-risk indicators flagged. Patterns the payer has historically rejected (observation status pre-admission, missing therapy eval, ambiguous skilled need) called out before acceptance.
Where MA decisions go wrong
The four failure modes admissions teams see most often.
Bed held before payer verified
Acceptance moves faster than the payer portal check. Network status, benefit period, or member ID turns out wrong on day 2, and the bed is already held. AdmitScore surfaces payer signals alongside the clinical review so staff can verify before the hold.
Carve-outs missed in the packet
A high-cost medication or a behavioral health carve-out only surfaces when the pharmacy bill arrives. AdmitScore flags carve-out exposure in the medication + care-cost surface so finance sees it before acceptance, not after.
Authorization scope assumed, not confirmed
"We'll get more days later" doesn't always work. AdmitScore separates authorized initial days from the escalation pathway in the authorization-readiness surface so staff know exactly what's contracted and what isn't.
Clinical and financial pressure mixed
When the same readout shows clinical fit and revenue impact side-by-side, financial pressure can leak into clinical judgment. AdmitScore returns scores by role: Referral Fit (financial-free, all roles) stays on the clinical review; admin-only Financial Fit and Margin layer in PDPM and denial-risk for administrators.
Related admissions resources
Connect payer review to the rest of the admission decision.
These public pages use synthetic or general examples only. They frame questions staff should verify before acceptance.
PDPM admissions signals
Admissions-level PDPM indicators that should be interpreted as planning context, not reimbursement guarantees.
ExaCare alternative
A focused comparison for teams weighing broad post-acute AI platforms against a narrower SNF referral review workflow.
Plain-English disclaimer
AdmitScore supports payer review; staff verify and decide.
No guaranteed authorization
Outputs are review aids and should not be represented as payer approval.
No guaranteed denial prevention
The product helps flag potential issues, but payer outcomes still depend on payer rules and documentation.
Source verification required
AI-extracted payer and clinical information should be verified against source documents.
Facility staff make final decisions
Clinical, operational, payer, and legal judgment remains with the facility.
FAQ
Medicare Advantage authorization readiness questions.
Does AdmitScore guarantee Medicare Advantage authorization approval?
No. AdmitScore helps staff review authorization readiness and possible documentation gaps, but payer approval depends on payer rules, source documentation, and staff verification.
What should SNF staff verify before accepting a Medicare Advantage referral?
Staff should verify payer, member eligibility, network status, initial authorization scope, continued-stay review expectations, skilled-need support, carve-outs, and missing documentation.
How does AdmitScore support MA authorization readiness?
AdmitScore surfaces payer, documentation, medication, and clarification questions from the referral packet so facility staff can verify source documents before bed hold.
How often do Medicare Advantage plans deny SNF prior authorization requests?
In a June 2026 report (OEI-09-24-00331), HHS OIG found that 19 reviewed Medicare Advantage organizations denied 12% of SNF admission prior-authorization requests in June 2024. Rates ranged from 0.4% to 23% by insurer, so the plan on the face sheet matters. Staff verify each referral against that payer's own requirements.
What share of appealed SNF prior-authorization denials get overturned?
HHS OIG found Medicare Advantage plans overturned 95% of appealed SNF denials in favor of the enrollee, but only 18% of denials were appealed at all. The overturn rate describes the small appealed share, not the odds on any single case. Appeals are neither futile nor automatic wins.
What should a SNF do when a Medicare Advantage prior-authorization denial arrives?
Teams typically verify the written denial reason, the appeal deadline printed on the denial notice, and the plan's reconsideration process, then assemble the documentation the notice cites as missing. Facility staff make the final decision on every case. No tool or checklist guarantees an overturn.